145 related articles for article (PubMed ID: 34313784)
21. Radixin knockdown improves the accumulation and efficiency of methotrexate in tumor cells.
Kawase A; Inoue Y; Nakazaki S; Koizumi E; Iwaki M
Oncol Rep; 2019 Jul; 42(1):283-290. PubMed ID: 31115547
[TBL] [Abstract][Full Text] [Related]
22. Snail-Induced Epithelial-to-Mesenchymal Transition Enhances P-gp-Mediated Multidrug Resistance in HCC827 Cells.
Tomono T; Yano K; Ogihara T
J Pharm Sci; 2017 Sep; 106(9):2642-2649. PubMed ID: 28322937
[TBL] [Abstract][Full Text] [Related]
23. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
24. Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement.
Adyshev DM; Moldobaeva NK; Elangovan VR; Garcia JG; Dudek SM
Cell Signal; 2011 Dec; 23(12):2086-96. PubMed ID: 21864676
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel-resistance conferred by altered expression of efflux and influx transporters for paclitaxel in the human hepatoma cell line, HepG2.
Takano M; Otani Y; Tanda M; Kawami M; Nagai J; Yumoto R
Drug Metab Pharmacokinet; 2009; 24(5):418-27. PubMed ID: 19881253
[TBL] [Abstract][Full Text] [Related]
26. Osmotic cell shrinkage activates ezrin/radixin/moesin (ERM) proteins: activation mechanisms and physiological implications.
Rasmussen M; Alexander RT; Darborg BV; Møbjerg N; Hoffmann EK; Kapus A; Pedersen SF
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C197-212. PubMed ID: 17977945
[TBL] [Abstract][Full Text] [Related]
27. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
Sikorska J; Gaweł D; Domek H; Rudzińska M; Czarnocka B
BMC Cancer; 2019 Jan; 19(1):85. PubMed ID: 30654768
[TBL] [Abstract][Full Text] [Related]
28. Functional Alterations of Multidrug Resistance-Associated Proteins 2 and 5, and Breast Cancer Resistance Protein upon Snail-Induced Epithelial-Mesenchymal Transition in HCC827 Cells.
Yano K; Todokoro I; Kamioka H; Tomono T; Ogihara T
Biol Pharm Bull; 2021; 44(1):103-111. PubMed ID: 33390536
[TBL] [Abstract][Full Text] [Related]
29. Apical-basal polarity inhibits epithelial-mesenchymal transition and tumour metastasis by PAR-complex-mediated SNAI1 degradation.
Jung HY; Fattet L; Tsai JH; Kajimoto T; Chang Q; Newton AC; Yang J
Nat Cell Biol; 2019 Mar; 21(3):359-371. PubMed ID: 30804505
[TBL] [Abstract][Full Text] [Related]
30. Slug Mediates MRP2 Expression in Non-Small Cell Lung Cancer Cells.
Zhang X; Liu W; Edaki K; Nakazawa Y; Takahashi S; Sunakawa H; Mizoi K; Ogihara T
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740931
[TBL] [Abstract][Full Text] [Related]
31. FBXW7 suppresses epithelial-mesenchymal transition and chemo-resistance of non-small-cell lung cancer cells by targeting snai1 for ubiquitin-dependent degradation.
Xiao G; Li Y; Wang M; Li X; Qin S; Sun X; Liang R; Zhang B; Du N; Xu C; Ren H; Liu D
Cell Prolif; 2018 Oct; 51(5):e12473. PubMed ID: 30094882
[TBL] [Abstract][Full Text] [Related]
32. The effect of radixin knockdown on the expression and efflux function of MRP2 in SGC-7901 cells.
He XJ; Wang WR; Zhang Y; Yang Q
Eur J Pharm Sci; 2012 Aug; 46(5):426-34. PubMed ID: 22469515
[TBL] [Abstract][Full Text] [Related]
33. Reversal of multi-drug resistance by pSUPER-shRNA-mdr1 in vivo and in vitro.
Pan GD; Yang JQ; Yan LN; Chu GP; Liu Q; Xiao Y; Yuan L
World J Gastroenterol; 2009 Jan; 15(4):431-40. PubMed ID: 19152447
[TBL] [Abstract][Full Text] [Related]
34. Glucosamine Reverses P-Glycoprotein-Mediated Multidrug Resistance in the Daunorubicin-Resistant Human Gastric Cancer Cells.
Valinezhad Sani F; Mosaffa F; Jamialahmadi K; Palizban A
Nutr Cancer; 2020; 72(3):522-527. PubMed ID: 31290701
[TBL] [Abstract][Full Text] [Related]
35. Novel role of Snail 1 in promoting tumor neoangiogenesis.
Zhang YK; Wang H; Guo YW; Yue Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30975732
[TBL] [Abstract][Full Text] [Related]
36. [Expression of ABCG2 and p-glycoprotein in residual breast cancer tissue after chemotherapy and their correlation with epithelial-mesenchymal transition].
Qu H; Fang L; Duan L; Long X
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):236-40. PubMed ID: 24915813
[TBL] [Abstract][Full Text] [Related]
37. Advances in Studies of P-Glycoprotein and Its Expression Regulators.
Yano K; Tomono T; Ogihara T
Biol Pharm Bull; 2018; 41(1):11-19. PubMed ID: 29311472
[TBL] [Abstract][Full Text] [Related]
38. Gambogenic acid reverses P-glycoprotein mediated multidrug resistance in HepG2/Adr cells and its underlying mechanism.
Xu Q; Guo J; Chen W
Biochem Biophys Res Commun; 2019 Jan; 508(3):882-888. PubMed ID: 30538042
[TBL] [Abstract][Full Text] [Related]
39. Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites.
Teng YN; Huang BH; Huang SY; Wu IT; Wu TS; Lee TE; Hung CC
Biomed Pharmacother; 2021 Dec; 144():112379. PubMed ID: 34794239
[TBL] [Abstract][Full Text] [Related]
40. Effect of Thai plant extracts on P-glycoprotein function and viability in paclitaxel-resistant HepG2 cells.
Kawami M; Yumoto R; Nagai J; Junyaprasert VB; Soonthornchareonnon N; Patanasethanont D; Sripanidkulchai BO; Takano M
Drug Metab Pharmacokinet; 2010; 25(2):155-62. PubMed ID: 20460821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
